At its most recent meeting, Germany’s Expert Committee on Prescription, the SVA, has recommended the Rx-to-OTC switch of an azelastine and fluticasone propionate combination nasal spray.
The second attempt by an undisclosed applicant – likely Viatris, which markets a prescription azelastine and fluticasone propionate combination nasal...







